Correlation between Bcl-2 expression and histopathology in diethylnitrosamine-induced mouse hepatocellular tumors

American Journal of Pathology

Volumn 151, Issue 4, 1997, Pages 957-961

  Lee, Gang Hong ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLNITROSAMINE; PHENOBARBITAL; PROTEIN BCL 2;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BASOPHIL; DIAGNOSIS; FEMALE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; QUALITATIVE DIAGNOSIS;

ANIMALS; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; DIETHYLNITROSAMINE; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 0030874843     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Tsujimoto Y, Finger LR, Yunis J, Nowell PC, Croce CM: Cloning of the chromosome break point of neoplastic B cells with the t(14;18) chromosome translocation. Science 1984, 226:1097-1099
2. Tsujimoto Y, Gorham J, Cossman J, Jaffe E, Croce CM: The t(14;18) chromosome translocation involved in B-cell neoplasms results from mistakes in VDJ joining. Science 1985, 229:1390-1393
3. Bakhshi A, Jensen JP, Goldman P: Cloning the chromosomal break point of t(14;18) human lymphomas: clustering around JH on chromosome 14 and near a transcriptional unit on 18. Cell 1985, 41:899-906
4. Cleary ML, Sklar J: Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18. Proc Natl Acad Sci USA 1985, 82:7439-7443
5. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988, 335:440-442
6. Korsmyer SJ: Bcl-2 initiates a new category of oncogenes: regulators of cell death. Blood 1992, 80:879-886
7. Vaux DL: Toward an understanding of the molecular mechanisms of physiological cell death. Proc Natl Acad Sci USA 1993, 90:786-789
8. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994, 124:1-6
9. Chen-Levy Z, Cleary ML: Membrane topology of the Bcl-2 protooncogenic protein demonstrated in vitro. J Biol Chem 1990, 25:4929-4933
10. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Hoffman B, Lieberman D, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9:1799-1805
11. Pilot HC, Sirica AE: The stages of initiation and promotion in hepatocarcinogenesis. Biochim Biophys Acta 1980, 605:191-215
12. Moore MA, Kitagawa T: Hepatocarcinogenesis in the rat: the effects of promoters and carcinogens in vivo and in vitro. Int Rev Cytol 1986, 101:125-173
13. Farber E, Sarma DSR: Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest 1987, 56:4-19
14. Schulte-Hermann R, Grasl-Kraupp B, Bursch W: Apoptosis and hepatocarcinogenesis. Liver Regeneration and Carcinogenesis: Molecular and Cellular Mechanisms. Edited by RL Jirtle. San Diego, CA, Academic Press, pp 141-178
15. Schulte-Hermann R, Timmermann-Troisiener I, Barthel G, Bursch W: DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion. Cancer Res 1990, 50:5127-5135
16. Vesselinovitch SD, Mihailovich N: Kinetics of diethylnitrosamine hepatocarcinogenesis in the infant mouse. Cancer Res 1983, 43:4253-4259
17. Frith CH, Ward JM: A morphologic classification of proliferative and neoplastic hepatic lesions in mice. J Environ Pathol Toxicol 1979, 3:329-351
18. 1 mice. Carcinogenesis 1983, 4:1021-1029
19. Rumsby PC, Barrass NC, Phillimore HE, Evans JG: Analysis of the Ha-ras oncogene in C3H/He mouse liver tumours derived spontaneously or induced with diethylnitrosamine or phenobarbitone. Carcinogenesis 1991, 12:2331-2336
20. Reddy AL, Fialkow PJ: Papillomas induced by initiation promotion differ from those induced by carcinogen alone. Nature 1983, 304: 69-71
21. Charlotte F, L'Hermine A, Martin N, Geleyn Y, Nollet M, Gaulard P, Zafrani ES: Immunohistochemical detection of bcl-2 protein in normal and pathological human liver. Am J Pathol 1994, 144:460-465
22. Fausto N: Hepatocyte differentiation and liver progenitor cells. Curr Opin Cell Biol 1990, 2:1036-1042
23. Marceau N: Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms. Lab Invest 1990, 63:4-20
24. Columbano A, Ledda-Columbano GM, Rao PM, Rajalakshmi S, Sarma DSR: Occurrence of cell death (apoptosis) in preneoplastic and neoplastic liver cells: a sequential study. Am J Pathol 1984, 116:441-446
25. Columbano A, Ledda-Columbano GM, Lee G, Rajalakshmi S, Sarma DS: Inability of mitogen-induced liver hyperplasia to support the induction of enzyme-altered islands induced by liver carcinogens. Cancer Res 1987, 47:5557-5559
26. Ledda-Columbano GM, Columbano A: Apoptosis and hepatocarcinogenesis. The Molecular Basis of Cell Death. Edited by LD Tomei, FO Cope. Cold Spring Harber, NY, Cold Spring Harber Laboratory Press, pp 101-119
27. Marsman DS, Barrett JC: Apoptosis and chemical carcinogenesis. Risk Analysis 1994, 14:321-326
28. Tsuda H, Hirohashi S, Shimosato Y, Ino Y, Yoshida T, Terada M: Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma. Jpn J Cancer Res 1989, 80:196-199
29. Doull J: The mouse in safety evaluation. Arch Toxicol 1987, 10:3-9